World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 4 January 2016
Main ID:  NCT02156700
Date of registration: 12/05/2014
Prospective Registration: No
Primary sponsor: University Hospital Dubrava
Public title: Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors
Scientific title: Quantitative Real-time Ultrasound Elastography (Shear Wave Elastography - SWE™) for Characterisation of Liver Tumors
Date of first enrolment: September 2013
Target sample size: 196
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02156700
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Cross-Sectional  
Phase:  N/A
Countries of recruitment
Croatia
Contacts
Name:     Ivica Grgurevic, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital Dubrava
Key inclusion & exclusion criteria

Inclusion Criteria:

- liver tumors detected on US examination of the liver

- compliance to the study protocol

- signed approval for the diagnostic ultrasound with SWE™

Exclusion Criteria:

- haemangioma, focal nodular hyperplasia (FNH), metastasis, cholangiocellular carcinoma
(CCC) or hepatocellular carcinoma (HCC) in the proximity of liver capsule (less than
1 cm from the liver surface)

- haemangioma, FNH, metastasis, CCC or HCC deep in the lever parenchyma (more than 7 cm
away from the surface)

- liver tumors other than haemangioma, FNH, metastasis, CCC and HCC

- severe hepatitis defined by alanine aminotransferase (ALT) values > 5 x upper limit
of normal (ULN)

- obstructive jaundice

- congestive heart failure

- pregnancy



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Focal Nodular Hyperplasia
Haemangioma
Hepatocellular Carcinoma
Cholangiocellular Carcinoma
Metastases
Intervention(s)
Procedure: Shear wave elastography
Primary Outcome(s)
Tumor stiffness [Time Frame: at the time of enrollment]
Secondary Outcome(s)
tumor to parenchyma stiffness ratio [Time Frame: at the time of enrollment]
Secondary ID(s)
KBD-IG1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history